Correction: Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan
Health Econ Rev
.
2023 Jan 11;13(1):3.
doi: 10.1186/s13561-023-00418-x.
Authors
Yuki Takumoto
1
2
,
Yuriko Sasahara
3
,
Hiroto Narimatsu
4
5
6
,
Tatsunori Murata
7
,
Manabu Akazawa
8
Affiliations
1
Department of Public Health and Epidemiology, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo, Japan.
2
Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Saitama, Japan.
3
Department of Medical Oncology, Yamagata Prefectural Central Hospital, Yamagata, Japan.
4
Department of Genetic Medicine, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
5
Cancer Prevention and Cancer Control Division, Kanagawa Cancer Center Research Institute, Yokohama, Kanagawa, Japan.
6
Graduate School of Health Innovation, Kanagawa University of Human Services, Yokohama, Kanagawa, Japan.
7
CRECON Medical Assessment Inc, Tokyo, Japan.
8
Department of Public Health and Epidemiology, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo, Japan. makazawa@my-pharm.ac.jp.
PMID:
36629978
PMCID:
PMC9832731
DOI:
10.1186/s13561-023-00418-x
No abstract available
Publication types
Published Erratum